Short Description

Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm (MPN) and myelodysplastic syndrome (MDS). CMML is characterized by a peripheral blood monocytosis accompanied by bone marrow dysplasia and cytopenias. The sequencing of genes for CMML helps in making diagnosis, and also for prognostication and therapeutics decision making.

PreTest Information

Duly filled NGS Test Requisition Form (Form 40) is mandatory.

Detail Description

ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL Test cost INR:40950 symptoms diagnosis

Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer that affects the white blood cells. It is a combination of both myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). CMML is often difficult to diagnose because its symptoms are similar to those of other illnesses. However, with the help of the ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL test, it is possible to accurately diagnose CMML.

Symptoms of CMML

The symptoms of CMML are similar to those of other illnesses, which can make it difficult to diagnose. Some of the common symptoms of CMML include:

• Fever
• Chills
• Night sweats
• Fatigue
• Shortness of breath
• Weight loss
• Easy bruising or bleeding
• Frequent infections
• Enlarged spleen or liver

Diagnosis of CMML

CMML can be diagnosed through a combination of blood tests, bone marrow tests, and imaging tests. The ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL test is a useful tool in diagnosing CMML. It is a genetic test that analyzes specific genes in a patient’s blood to determine if they have CMML.

ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL Test

The ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL test is a genetic test that analyzes specific genes in a patient’s blood to determine if they have CMML. It is a reliable and accurate way to diagnose CMML. The test costs INR 40950.

The ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL test is a comprehensive test that analyzes 14 genes associated with CMML. The genes that are analyzed include:

• ASXL1
• CBL
• DNMT3A
• EZH2
• FLT3
• IDH1
• IDH2
• JAK2
• KRAS
• NPM1
• NRAS
• SF3B1
• SRSF2
• TP53

The ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL test is a non-invasive test that requires only a small blood sample. The results of the test are usually available within a few days.

Conclusion

CMML is a rare type of blood cancer that can be difficult to diagnose. However, with the help of the ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL test, it is possible to accurately diagnose CMML. The test costs INR 40950 and analyzes 14 genes associated with CMML. If you are experiencing symptoms of CMML, it is important to speak with your doctor about getting tested.

DNA Labs India is a leading provider of genetic testing services in India. To learn more about the ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL test, contact DNA Labs India today.

Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm (MPN) and myelodysplastic syndrome (MDS). CMML is characterized by a peripheral blood monocytosis accompanied by bone marrow dysplasia and cytopenias. The sequencing of genes for CMML helps in making diagnosis, and also for prognostication and therapeutics decision making.